MAGN Earnings

MAGN reported its earnings on 2026-02-05, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MAGN's earnings announcement on 2026-02-05, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, MAGN's stock price tends to shift by an average of -14.54% in the 10 days leading up to earnings and +38.80% in the 10 days following, providing insight into potential market.

For , analysts estimate MAGN’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -1.57% and EPS estimates Revise Downward by -3.93% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between MAGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Downward by -1.57%, while EPS estimates moved Revise Downward by -3.93% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MAGN's stock price typically moves by -14.54% in the 10 days before its earnings and +38.80% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call shows mixed signals: strong growth in infection prevention wipes and operational efficiencies, but revenue declines in key segments. Positive aspects include EBITDA margin expansion and Project CORE's future benefits. However, cautious demand, unclear management responses, and regional challenges offset these. The Q&A highlights synergy realization and cautious optimism, but concerns about South America and Europe persist. The absence of a market cap limits prediction precision, but the balanced positives and negatives suggest a neutral stock price movement in the short term.